TRIALCHAT: Leveraging LLMs to enhance AD/ADRD clinical trial participation
Tim K. Mackey, S-3 Research LLC, Joshua Yang, California State University, Fullerton. This project will aim to develop TrialChat, an AI-powered chatbot and clinical trial navigator designed to increase participation in Alzheimer’s disease and related dementias (ADRD) clinical trials by providing tailored education, personalized trial matching, and recruitment support for older adults and caregivers.